Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ticlopidine induced cholestatic jaundice

H B Yim1, P K Lieu, P W Choo

  • 1Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore.

Singapore Medical Journal
|March 1, 1997
PubMed
Summary

Ticlopidine hydrochloride, an antiplatelet drug, may rarely cause cholestatic jaundice. This case report highlights a rare but serious side effect of this commonly used medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary analysis of phosphorus flow in Hue Citadel.

Water science and technology : a journal of the International Association on Water Pollution Research·2016
Same author

Characterization of water pollution in drainage networks using continuous monitoring data in the Citadel area of Hue City, Vietnam.

Water science and technology : a journal of the International Association on Water Pollution Research·2014
Same author

Development of single-stage nitrogen removal using anammox and partial nitritation (SNAP) and its treatment performances.

Water science and technology : a journal of the International Association on Water Pollution Research·2006
Same author

Safety of endoscopical procedures during pregnancy.

Singapore medical journal·2006
Same author

Endoscopic retrograde cholangiopancreatography in the elderly: outcomes, safety and complications.

Singapore medical journal·2005
Same author

Clinical usefulness of endoscopic ultrasonography with or without fine needle aspiration in the diagnosis and staging of pancreatic carcinoma.

Annals of the Academy of Medicine, Singapore·2005

Area of Science:

  • Pharmacology
  • Hepatology
  • Clinical Medicine

Background:

  • Ticlopidine hydrochloride is a widely used antiplatelet medication.
  • It demonstrates significant efficacy in preventing stroke recurrence, potentially exceeding that of aspirin.
  • Common side effects include gastrointestinal disturbances and blood dyscrasias.

Observation:

  • A rare case of ticlopidine-induced cholestatic jaundice is presented.
  • This adverse event is infrequently reported in medical literature.
  • The patient experienced jaundice as a consequence of ticlopidine hydrochloride administration.

Findings:

  • Ticlopidine hydrochloride, despite its benefits, carries a risk of rare but severe hepatotoxicity.
  • Cholestatic jaundice is an identified, albeit uncommon, adverse reaction.
  • The case underscores the importance of monitoring liver function in patients on ticlopidine therapy.

Implications:

  • Clinicians should be aware of the potential for ticlopidine-induced cholestatic jaundice.
  • Early recognition and management are crucial for patients developing jaundice while on ticlopidine.
  • This case contributes to the understanding of rare adverse drug reactions in antiplatelet therapy.

Related Experiment Videos